{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:12:09Z","timestamp":1793319129875,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Spanish Ministry of Science, Innovation and Universities","award":["PI12\/01907"],"award-info":[{"award-number":["PI12\/01907"]}]},{"name":"Spanish Network for Research in Infectious Diseases","award":["RD16\/0016\/0005"],"award-info":[{"award-number":["RD16\/0016\/0005"]}]},{"name":"Subdirecci\u00f3n General de Evaluaci\u00f3n y Fomento de la Investigaci\u00f3n","award":["PT13\/0002\/0007"],"award-info":[{"award-number":["PT13\/0002\/0007"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We aimed to determine whether daptomycin plus fosfomycin provides higher treatment success than daptomycin alone for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and endocarditis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A randomized (1:1) phase 3 superiority, open-label, and parallel group clinical trial of adult inpatients with MRSA bacteremia was conducted at 18 Spanish hospitals. Patients were randomly assigned to receive either 10 mg\/kg of daptomycin intravenously daily plus 2 g of fosfomycin intravenously every 6 hours, or 10 mg\/kg of daptomycin intravenously daily. Primary endpoint was treatment success 6 weeks after the end of therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 167 patients randomized, 155 completed the trial and were assessed for the primary endpoint. Treatment success at 6 weeks after the end of therapy was achieved in 40 of 74 patients who received daptomycin plus fosfomycin and in 34 of 81 patients who were given daptomycin alone (54.1% vs 42.0%; relative risk, 1.29 [95% confidence interval, .93\u20131.8]; P\u2005=\u2005.135). At 6 weeks, daptomycin plus fosfomycin was associated with lower microbiologic failure (0 vs 9 patients; P\u2005=\u2005.003) and lower complicated bacteremia (16.2% vs 32.1%; P\u2005=\u2005.022). Adverse events leading to treatment discontinuation occurred in 13 of 74 patients (17.6%) receiving daptomycin plus fosfomycin, and in 4 of 81 patients (4.9%) receiving daptomycin alone (P\u2005=\u2005.018).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Daptomycin plus fosfomycin provided 12% higher rate of treatment success than daptomycin alone, but this difference did not reach statistical significance. This antibiotic combination prevented microbiological failure and complicated bacteremia, but it was more often associated with adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trials Registration<\/jats:title>\n                    <jats:p>NCT01898338.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaa1081","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T07:18:42Z","timestamp":1595834322000},"page":"1517-1525","source":"Crossref","is-referenced-by-count":140,"title":["Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant\n                    <i>Staphylococcus aureus<\/i>\n                    Bacteremia and Endocarditis: A Randomized Clinical Trial"],"prefix":"10.1093","volume":"72","author":[{"given":"Miquel","family":"Pujol","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut Investigacions Biom\u00e8diques de Bellvitge, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Mar\u00eda","family":"Mir\u00f3","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Clinic, Institut d\u2019Investigacions Biom\u00e8diques Agust Pi i Sunyer, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Shaw","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut Investigacions Biom\u00e8diques de Bellvitge, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose-Mar\u00eda","family":"Aguado","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario 12 Octubre, Instituto de Investigaci\u00f3n Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3446-1991","authenticated-orcid":false,"given":"Rafael","family":"San-Juan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario 12 Octubre, Instituto de Investigaci\u00f3n Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Puig-Asensio","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Vall d\u2019Hebron, Vall d\u2019Hebron Institut de Recerca, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Pigrau","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Vall d\u2019Hebron, Vall d\u2019Hebron Institut de Recerca, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Calbo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Hospital Universitari M\u00fatua de Terrassa, Fundaci\u00f3 Doc\u00e8ncia i Recerca M\u00fatua de Terrassa, Universitat Internacional de Catalunya, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Montejo","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario Cruces, Biocruces Bizkaia, Bilbao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regino","family":"Rodriguez-\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario Cruces, Biocruces Bizkaia, Bilbao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Jose","family":"Garcia-Pais","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Hospital Lucus Augusti, Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela, Lugo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Pintado","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario Ramon y Cajal, Instituto Ramon y Cajal de Investigaci\u00f3n Sanitaria, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Escudero-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario Ramon y Cajal, Instituto Ramon y Cajal de Investigaci\u00f3n Sanitaria, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Lopez-Contreras","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitari de Sant Pau, Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Morata","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Clinic, Institut d\u2019Investigacions Biom\u00e8diques Agust Pi i Sunyer, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Montero","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital del Mar, Institut de Recerca Hospital del Mar, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Andr\u00e9s","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, Consorci Sanitari de Terrassa, Terrassa, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Pasquau","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario Virgen de las Nieves, Instituto de Investigaci\u00f3n Sanitaria Granada, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-del-Mar","family":"Arenas","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario Virgen de las Nieves, Instituto de Investigaci\u00f3n Sanitaria Granada, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Padilla","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Infectious Diseases, Hospital Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Murillas","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital Universitari Son Espases, Fundaci\u00f3 Institut d\u2019Investigaci\u00f3 Sanit\u00e0ria Illes Balears, Mallorca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Jover-S\u00e1enz","sequence":"additional","affiliation":[{"name":"Territorial Unit of Nosocomial Infection, Hospital Universitari Arnau de Vilanova, Institut de Recerca Biom\u00e8dica de Lleida, Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis-Eduardo","family":"L\u00f3pez-Cortes","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitario Virgen Macarena, Instituto de Biomedicina de Sevilla, Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciano","family":"Garc\u00eda-Pardo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital Universitari Joan XXIII, Universitat Rovira i Virgili, Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Gasch","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Consorci Sanitari Hospital Parc Taul\u00ed, Fundaci\u00f3 Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Videla","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Institut Investigacions Biom\u00e8diques de Bellvitge, Clinical Research and Clinical Trials Unit, Plataforma Spanish Clinical Research Network, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Hereu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Institut Investigacions Biom\u00e8diques de Bellvitge, Clinical Research and Clinical Trials Unit, Plataforma Spanish Clinical Research Network, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Teb\u00e9","sequence":"additional","affiliation":[{"name":"Biostatistics Unit, Institut Investigacions Biom\u00e8diques de Bellvitge, L\u2019Hospitalet Llobregat, L\u2019Hospitalet del Llobregat, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Pallar\u00e8s","sequence":"additional","affiliation":[{"name":"Biostatistics Unit, Institut Investigacions Biom\u00e8diques de Bellvitge, L\u2019Hospitalet Llobregat, L\u2019Hospitalet del Llobregat, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Sanllorente","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Institut Investigacions Biom\u00e8diques de Bellvitge, Clinical Research and Clinical Trials Unit, Plataforma Spanish Clinical Research Network, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-\u00c1ngeles","family":"Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Parasitology, Hospital Universitari de Bellvitge, Institut Investigacions Biom\u00e8diques de Bellvitge, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"C\u00e0mara","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Parasitology, Hospital Universitari de Bellvitge, Institut Investigacions Biom\u00e8diques de Bellvitge, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ferrer","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hospital Universitari de Bellvitge, Institut Investigacions Biom\u00e8diques de Bellvitge, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna","family":"Padull\u00e9s","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hospital Universitari de Bellvitge, Institut Investigacions Biom\u00e8diques de Bellvitge, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Cuervo","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut Investigacions Biom\u00e8diques de Bellvitge, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Carratal\u00e0","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hospital Universitari de Bellvitge, Institut Investigacions Biom\u00e8diques de Bellvitge, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MRSA Bacteremia (BACSARM) Trial Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Almela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Mirelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dolores P\u00e9rez-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateu","family":"Espasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Maria S\u00e1nchez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Cercenado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Ruiz de Gopegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Siverio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"de Cueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Garc\u00eda-Garrote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Xercavins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nieves Larrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"2021050500370637000_CIT0001","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMp0804651","article-title":"Antibiotic-resistant bugs in the 21st century\u2014a clinical super-challenge","volume":"360","author":"Arias","year":"2009","journal-title":"N Engl J Med"},{"key":"2021050500370637000_CIT0002","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/1469-0691.12108","article-title":"Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy","volume":"19","author":"Gasch","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"2021050500370637000_CIT0003","first-page":"2112","article-title":"Methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia: nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the United States","volume":"69","author":"Inagaki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021050500370637000_CIT0004","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/jac\/dkn372","article-title":"Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates","volume":"62","author":"Rehm","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2021050500370637000_CIT0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e31822f0b54","article-title":"Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection: secular trends over 19 years at a university hospital","volume":"90","author":"Gasch","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"2021050500370637000_CIT0006","doi-asserted-by":"crossref","first-page":"e0170236","DOI":"10.1371\/journal.pone.0170236","article-title":"Characteristics of Staphylococcus aureus bacteraemia and predictors of early and late mortality","volume":"12","author":"Bassetti","year":"2017","journal-title":"PLoS One"},{"key":"2021050500370637000_CIT0007","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2021050500370637000_CIT0008","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42(Suppl 1)","author":"Levine","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2021050500370637000_CIT0009","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/jama.2014.6364","article-title":"Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis","volume":"312","author":"Kalil","year":"2014","journal-title":"JAMA"},{"key":"2021050500370637000_CIT0010","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/cid\/ciz460","article-title":"The emperor\u2019s new clothes: prospective observational evaluation of the association between initial vancomycin exposure and failure rates among adult hospitalized patients with MRSA bloodstream infections (PROVIDE)","volume":"70","author":"Lodise","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021050500370637000_CIT0011","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cid\/civ808","article-title":"Combination of vancomycin and \u03b2-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial","volume":"62","author":"Davis","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2021050500370637000_CIT0012","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.2020.0103","article-title":"Effect of vancomycin or daptomycin with vs without an antistaphylococcal \u03b2-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia","volume":"323","author":"Tong","year":"2020","journal-title":"JAMA"},{"key":"2021050500370637000_CIT0013","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(17)32456-X","article-title":"Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Thwaites","year":"2018","journal-title":"Lancet"},{"key":"2021050500370637000_CIT0014","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"2021050500370637000_CIT0015","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkt396","article-title":"Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin","volume":"69","author":"Gasch","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2021050500370637000_CIT0016","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/CMR.00068-15","article-title":"Fosfomycin","volume":"29","author":"Falagas","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"2021050500370637000_CIT0017","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/CMR.00030-13","article-title":"A current perspective on daptomycin for the clinical microbiologist","volume":"26","author":"Humphries","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"2021050500370637000_CIT0018","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijantimicag.2018.09.013","article-title":"Resistance to fosfomycin: mechanisms, frequency and clinical consequences","volume":"53","author":"Falagas","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"2021050500370637000_CIT0019","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1128\/AAC.02139-15","article-title":"Fosfomycin plus \u03b2-lactams as synergistic bactericidal combinations for experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus","volume":"60","author":"del R\u00edo","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2021050500370637000_CIT0020","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1128\/AAC.00594-13","article-title":"\u03b2-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus","volume":"57","author":"Berti","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021050500370637000_CIT0021","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1128\/AAC.00799-13","article-title":"Daptomycin in vitro activity against methicillin-resistant Staphylococcus aureus is enhanced by d-cycloserine in a mechanism associated with a decrease in cell surface charge","volume":"57","author":"Gasch","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021050500370637000_CIT0022","doi-asserted-by":"crossref","first-page":"e02633-17","DOI":"10.1128\/AAC.02633-17","article-title":"The combination of daptomycin and fosfomycin has synergistic, potent, and rapid bactericidal activity against methicillin-resistant Staphylococcus aureus in a rabbit model of experimental endocarditis","volume":"62","author":"Garc\u00eda-de-la-M\u00e0ria","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2021050500370637000_CIT0023","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/cid\/ciu580","article-title":"Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial","volume":"59","author":"del R\u00edo","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021050500370637000_CIT0024","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1128\/AAC.06449-11","article-title":"High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis","volume":"56","author":"Mir\u00f3","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2021050500370637000_CIT0025","doi-asserted-by":"crossref","first-page":"e006723","DOI":"10.1136\/bmjopen-2014-006723","article-title":"Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial","volume":"5","author":"Shaw","year":"2015","journal-title":"BMJ Open"},{"key":"2021050500370637000_CIT0026","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/JCM.33.9.2233-2239.1995","article-title":"Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing","volume":"33","author":"Tenover","year":"1995","journal-title":"J Clin Microbiol"},{"key":"2021050500370637000_CIT0027","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2021050500370637000_CIT0028","author":"International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use","year":"1996"},{"key":"2021050500370637000_CIT0029","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/cid\/ciy766","article-title":"Good studies evaluate the disease while great studies evaluate the patient: development and application of a desirability of outcome ranking endpoint for Staphylococcus aureus bloodstream infection","volume":"68","author":"Doernberg","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021050500370637000_CIT0030","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/cid\/ciz257","article-title":"Defining the breakpoint duration of Staphylococcus aureus bacteremia predictive of poor outcomes","volume":"70","author":"Minejima","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021050500370637000_CIT0031","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/eurheartj\/ehs379","article-title":"Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis","volume":"34","author":"L\u00f3pez","year":"2013","journal-title":"Eur Heart J"},{"key":"2021050500370637000_CIT0032","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijantimicag.2010.09.002","article-title":"Adverse events associated with intravenous fosfomycin","volume":"37","author":"Florent","year":"2011","journal-title":"Int J Antimicrob Agents"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1081\/33881479\/ciaa1081.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/9\/1517\/37793691\/ciaa1081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/9\/1517\/37793691\/ciaa1081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T20:42:55Z","timestamp":1620160975000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/72\/9\/1517\/5877897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,7,29]]},"published-print":{"date-parts":[[2021,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1081","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738406286.793587627","asserted-by":"object"}]},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2020,7,29]]}}}